Nano-Based Drug Delivery Systems for Periodontal Tissue Regeneration
Huanhuan Chen1,2, Yunfan Zhang1,2, Tingting Yu1,2
1Department of Orthodontics, School and Hospital of Stomatology, Peking University, Beijing 100081, China.
Pharmaceutics
|October 27, 2022
Summary
Nano-based drug delivery systems offer a promising approach to treat periodontitis by improving drug efficacy and safety. These advanced systems aid in controlling inflammation and promoting periodontal tissue regeneration.
Area of Science:
- Biomaterials Science
- Periodontology
- Nanotechnology
Background:
- Periodontitis is a severe inflammatory gum disease causing tooth tissue destruction.
- Current treatments face challenges in efficacy and localized drug delivery.
- Periodontal defects impact oral function and aesthetics.
Purpose of the Study:
- To review nano-based drug delivery systems for periodontal tissue regeneration.
- To highlight their applications, potential, and limitations in periodontitis treatment.
Main Methods:
- Literature review of nano-based drug delivery systems in periodontology.
- Analysis of studies focusing on periodontal regeneration and inflammation control.
Main Results:
- Nano-based systems show enhanced biopharmaceutical and pharmacokinetic properties.
- They enable targeted and controlled drug release for improved treatment outcomes.
- These systems promote a regenerative environment for bone and attachment regrowth.
Conclusions:
- Nano-based drug delivery is a promising strategy for periodontal regeneration.
- Further research is needed to overcome limitations and optimize clinical application.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...